Galidesivir
id:
galidesivir-295-3163064
title:
Galidesivir
text:
Galidesivir is an antiviral drug, an adenosine analog. It was developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease, as well as Zika virus. Currently, galidesivir is under phase 1 human trial in Brazil for coronavirus. It also shows broad-spectrum antiviral effectiveness against a range of other RNA
brand slug:
wiki
category slug:
encyclopedia
description:
Antiviral drug
original url:
https://en.wikipedia.org/wiki/Galidesivir
date created:
date modified:
2023-12-16T20:05:44Z
main entity:
{"identifier":"Q18209997","url":"https://www.wikidata.org/entity/Q18209997"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4d/BCX4430.svg","width":512,"height":466}
fields total:
13
integrity:
15